Lipocalin 2-A bone-derived anorexigenic and β-cell promoting signal: From mice to humans.
Yu-Ying YangJian-Min LiuStavroula KousteniPublished in: Journal of diabetes (2023)
The skeleton is traditionally known for its structural support, organ protection, movement, and maintenance of mineral homeostasis. Over the last 10 years, bone has emerged as an endocrine organ with diverse physiological functions. The two key molecules in this context are fibroblast growth factor 23 (FGF23), secreted by osteocytes, and osteocalcin, a hormone produced by osteoblasts. FGF23 affects mineral homeostasis through its actions on the kidneys, and osteocalcin has beneficial effects in improving glucose homeostasis, muscle function, brain development, cognition, and male fertility. In addition, another osteoblast-derived hormone, lipocalin 2 (LCN2) has emerged into the researchers' field of vision. In this review, we mainly focus on LCN2's role in appetite regulation and glucose metabolism and also briefly introduce its effects in other pathophysiological conditions, such as nonalcoholic fatty liver disease, sarcopenic obesity, and cancer-induced cachexia.
Keyphrases
- high fat diet induced
- bone mineral density
- weight loss
- bone regeneration
- white matter
- insulin resistance
- papillary thyroid
- soft tissue
- type diabetes
- skeletal muscle
- single cell
- resting state
- cell therapy
- high glucose
- childhood cancer
- diabetic rats
- squamous cell
- mild cognitive impairment
- functional connectivity
- drug induced
- body composition
- blood pressure
- physical activity
- body mass index
- mesenchymal stem cells
- adipose tissue
- oxidative stress
- wild type
- lymph node metastasis
- endothelial cells